Replies to post #813756 on NorthWest Biotherapeutics Inc (NWBO)

[HappyLibrarian]

HL, i agree, none of us thought we will be like this in oct 2020, when we got the data lock. I was optimistic , we will be in hundred dollars price range in five years if we succeed in the trial. The interim trial results at that time were very encouraging for me and i jumped into this investment thinking its going to be a slamdunk investment in due course.The time line is not going as we anticipated. Thats all. but the drug is still very good and moved past many checks and the company is trying its best to straighten the manufacturing issues. If MHRA is acting irresponsibly and dragging its feet, we cannot completely blame nwbo for it. I hope they have their own good reasons for it. Moreover, nobody has the ability to predict future. So please wait for the result if you have the patience and energy. It has become an individual decision at this point about how to deal with this investment. This is just my opinion only.
Bullish

The problem is that a slight variation of your argument could have been made in October 2020 as even then it had taken a very long time just to get to data lock and lest we forget, even NWBO allegedly indicated in September 2020 we were going to get Top Line Data - not merely Data Lock in September 2020. So they were almost literally a day late and a dollar short even back then, which is why I called it a dark day.

Anyone who heeded the counsel to be patient has really suffered for it while those who took their losses and moved on would have been well served.

Saying it’s an individual decision is a bit of a cop out as it takes away our ability to unify and demand change at NWBO.

At what point should NWBO management go big or go home and give this technology a fighting chance in more competent hands?

Another 3 months?

Another 6 months?

Another year?

Another 5 years?

MHRA did not force NWBO to piss away two additional years getting TLD and more than three years just to apply in that one fairly small though developed country.